Clinical Trial Update: Multi-Centre Trial Comparing Three Artemisinin-Based Combination Treatments on P. Falciparum Malaria [Phase 3]

View source ↗

Summary

A Phase 3 multicentre trial comparing three artemisinin-based combination therapies for Plasmodium falciparum malaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• Artemisinin-based combination therapy (three regimens in trial)

Snippet

Sponsor: Dafra Pharma | Conditions: Plasmodium Falciparum Malaria | Phase 3 | Status: COMPLETED